Health Care & Life Sciences » Biotechnology | Nymox Pharmaceutical Corp.

Nymox Pharmaceutical Corp. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
3,359.00
2,949.50
2,761.30
284.00
224.00
299
Cost of Goods Sold (COGS) incl. D&A
495.30
180.30
166.30
176.00
150.00
141
Gross Income
2,863.80
2,769.20
2,594.90
108.00
74.00
158
SG&A Expense
8,303.70
7,758.70
20,255.30
12,978.00
13,309.00
10,799
EBIT
5,440.00
4,989.50
17,660.30
-
13,235.00
10,641
Unusual Expense
-
189.60
-
-
-
-
Non Operating Income/Expense
27.10
24.60
35.80
10.00
1.00
7
Interest Expense
-
86.80
187.80
234.00
204.00
18
Pretax Income
5,463.60
4,910.90
17,883.90
13,110.00
13,429.00
10,594
Income Tax
555.00
316.80
-
-
-
-
Consolidated Net Income
4,908.60
4,594.10
17,883.90
13,110.00
13,429.00
10,594
Net Income
4,908.60
4,594.10
17,883.90
13,110.00
13,429.00
10,594
Net Income After Extraordinaries
4,908.60
4,594.10
17,883.90
13,110.00
13,429.00
10,594
Net Income Available to Common
4,908.60
4,594.10
17,883.90
13,110.00
13,429.00
10,594
EPS (Basic)
0.14
0.13
0.48
0.16
0.26
0.18
Basic Shares Outstanding
34,147.70
35,253.90
37,402.60
46,155.00
52,648.00
60,466.40
EPS (Diluted)
0.14
0.13
0.48
0.28
0.26
0.18
Diluted Shares Outstanding
34,147.70
35,253.90
37,402.60
46,155.00
52,648.00
60,466.40
EBITDA
5,430.90
4,982.90
17,654.30
12,867.00
13,234.00
10,638
Non-Operating Interest Income
3.40
0.40
-
4.00
11.00
72

About Nymox Pharmaceutical

View Profile
Address
Bay & Deveaux Streets
Nassau NW
Bahamas
Employees -
Website http://www.nymox.com
Updated 07/08/2019
Nymox Pharmaceutical Corp.operates as a biopharmaceutical company, which engages in the research and development on products for the aging population. Its products include NicAlert and TobacAlert, and the NX-1207 for the treatment of low-grade localized prostate cancer. It operates through the following geographical segments: Canada, United States, and Europe.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.